rs281865090
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000195.5(HPS1):c.2003T>C(p.Leu668Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000195.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HPS1 | NM_000195.5 | c.2003T>C | p.Leu668Pro | missense_variant | Exon 20 of 20 | ENST00000361490.9 | NP_000186.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HPS1 | ENST00000361490.9 | c.2003T>C | p.Leu668Pro | missense_variant | Exon 20 of 20 | 1 | NM_000195.5 | ENSP00000355310.4 | ||
ENSG00000289758 | ENST00000699159.1 | n.*1347+15T>C | intron_variant | Intron 19 of 23 | ENSP00000514167.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461592Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727112
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hermansky-Pudlak syndrome Pathogenic:1
Variant summary: HPS1 c.2003T>C (p.Leu668Pro) results in a non-conservative amino acid change located in the FUZ/MON1/HPS1, third Longin domain (IPR043970) of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 248842 control chromosomes (gnomAD). c.2003T>C has been reported in the literature in multiple individuals affected with Hermansky-Pudlak Syndrome (e.g. Ito_2005, Kanazu_2014, Wei_2016). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, indicating that the variant results in instability of the protein (Ito_2005). The following publications have been ascertained in the context of this evaluation (PMID: 16185271, 25400188, 27593200). ClinVar contains an entry for this variant (Variation ID: 1499624). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 1499624). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 668 of the HPS1 protein (p.Leu668Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Hermansky-Pudlak syndrome (PMID: 16185271, 25400188, 27593200, 31141302, 32725903). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HPS1 protein function. Experimental studies have shown that this missense change affects HPS1 function (PMID: 16185271). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Hermansky-Pudlak syndrome 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at